✦ LIBER ✦

Long-term evaluation of treatment for chronic heart failure: A 1 year comparative trial of flosequinan and captopril

✍ Scribed by A. J. Cowley; D. J. McEntegart; J. R. Hampton; D. B. Barnett; R. S. Bexton; R. Boyle; S. P. Hanley; M. Millar-Craig; G. K. Morris; A. J. Nicholls; D. P. Nicholls; G. D. G. Oakley; R. D. Thomas; C. Ward; R. D. Wynne

Publisher: Springer US
Year: 1994
Tongue: English
Weight: 796 KB
Volume: 8
Category: Article
ISSN: 0920-3206
DOI: 10.1007/bf00877401

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant human growth hormone treatme

Recombinant human growth hormone treatment of children with chronic renal failure: long-term (1- to 3-year) outcome

✍ Richard N. Fine; Kim Pyke-Grimm; Pauline A. Nelson; M. Ines Boechat; Barbara M. 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 518 KB

Prediction of successful outcome in a ra

Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C

✍ Vandelli, Carmen; Renzo, Francesco; Braun, Hans Bertram; Tisminetzky, Sergio; Al 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

To evaluate the efficacy of a 12-month course of recombinant interferon alpha (IFN-␣2b), and to assess predictive factors of successful response to IFN therapy in chronic active hepatitis C (HCV CAH), 242 patients with histologically proven HCV CAH were assigned randomly to two groups, one treated w

A randomised controlled trial comparing

A randomised controlled trial comparing two autologous fascial sling techniques for the treatment of stress urinary incontinence in women: short, medium and long-term follow-up

✍ K. Guerrero; A. Watkins; S. Emery; K. Wareham; T. Stephenson; V. Logan; M. Lucas 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 162 KB

Lymphoblastoid interferon alfa-n1 improv

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l

Variants in interferon-alpha pathway gen

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may